Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation

Tanshinone IIA (Tan IIA) possesses potent anti-atherogenic function, however, the underlying pharmacological mechanism remains incompletely understood. Previous studies suggest that oxidized LDL (oxLDL)-induced NLRP3 (NOD-like receptor (NLR) family, pyrin domain-containing protein 3) inflammasome ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Jiexia, Chang, Yumei, Huo, Shanshan, Li, Wenyan, Huang, Heling, Gao, Yunhuan, Lin, Hongyu, Zhang, Jianlou, Zhang, Yonghong, Zuo, Yuzhu, Cao, Xuebin, Zhong, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835056/
https://www.ncbi.nlm.nih.gov/pubmed/33290264
http://dx.doi.org/10.18632/aging.202202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835056/
https://www.ncbi.nlm.nih.gov/pubmed/33290264
http://dx.doi.org/10.18632/aging.202202

Ejemplares similares